Further, when we stratified mutation frequencies for low- and high-grade adenoma, the distribution frequencies of mutations in the APC and TP53 genes had an increasing tendency towards in situ carcinoma, while the frequency of mutations in the KRAS gene in the low- and high-grade adenoma was lower than that in in situ carcinoma. The gene discussed is KRAS; the disease is in situ carcinoma.